Barclays PLC Grows Position in Astria Therapeutics, Inc. (NASDAQ:ATXS)
Barclays PLC raised its stake in Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) by 5.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 97,820 shares of the biotechnology company’s stock after acquiring an additional 5,169 shares during the quarter. Barclays PLC’s […]
Barclays PLC raised its stake in Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) by 5.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 97,820 shares of the biotechnology company’s stock after acquiring an additional 5,169 shares during the quarter. Barclays PLC’s […]
